Charles River Laboratories International Inc
NYSE:CRL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Charles River Laboratories International Inc
NYSE:CRL
|
US |
|
Alexander's Inc
NYSE:ALX
|
US |
|
Carlsberg A/S
CSE:CARL B
|
DK |
|
Inspired Entertainment Inc
NASDAQ:INSE
|
US |
|
B
|
Bunge Ltd
LSE:0U6R
|
US |
|
A
|
ams OSRAM AG
SWB:DQW1
|
AT |
|
P
|
Philippine Seven Corp
XPHS:SEVN
|
PH |
|
G
|
Gran Tierra Energy Inc
XBER:G1P
|
CA |
|
I
|
Intuit Inc
F:ITU
|
US |
|
A
|
Atlanta Braves Holdings Inc
NASDAQ:BATRK
|
US |
|
AJ Bell PLC
LSE:AJB
|
UK |
|
Mid-America Apartment Communities Inc
NYSE:MAA
|
US |
Wall St Price Targets
CRL Price Targets Summary
Charles River Laboratories International Inc
According to Wall Street analysts, the average 1-year price target for CRL is 218.22 USD with a low forecast of 144.55 USD and a high forecast of 278.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRL's stock price target?
Price Target
218.22
USD
According to Wall Street analysts, the average 1-year price target for CRL is 218.22 USD with a low forecast of 144.55 USD and a high forecast of 278.25 USD.
What is the Revenue forecast for Charles River Laboratories International Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Charles River Laboratories International Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Charles River Laboratories International Inc?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 21%.
